1. Home
  2. EVAX vs FOXO Comparison

EVAX vs FOXO Comparison

Compare EVAX & FOXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVAX
  • FOXO
  • Stock Information
  • Founded
  • EVAX 2008
  • FOXO 2019
  • Country
  • EVAX Denmark
  • FOXO United States
  • Employees
  • EVAX N/A
  • FOXO N/A
  • Industry
  • EVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • FOXO Retail: Computer Software & Peripheral Equipment
  • Sector
  • EVAX Health Care
  • FOXO Technology
  • Exchange
  • EVAX Nasdaq
  • FOXO Nasdaq
  • Market Cap
  • EVAX 8.7M
  • FOXO 8.0M
  • IPO Year
  • EVAX 2021
  • FOXO N/A
  • Fundamental
  • Price
  • EVAX $2.75
  • FOXO $0.23
  • Analyst Decision
  • EVAX Strong Buy
  • FOXO
  • Analyst Count
  • EVAX 3
  • FOXO 0
  • Target Price
  • EVAX $33.33
  • FOXO N/A
  • AVG Volume (30 Days)
  • EVAX 6.8M
  • FOXO 13.4M
  • Earning Date
  • EVAX 03-26-2025
  • FOXO 11-19-2024
  • Dividend Yield
  • EVAX N/A
  • FOXO N/A
  • EPS Growth
  • EVAX N/A
  • FOXO N/A
  • EPS
  • EVAX N/A
  • FOXO N/A
  • Revenue
  • EVAX $3,295,000.00
  • FOXO $1,341,000.00
  • Revenue This Year
  • EVAX $4,845.21
  • FOXO N/A
  • Revenue Next Year
  • EVAX $30.30
  • FOXO N/A
  • P/E Ratio
  • EVAX N/A
  • FOXO N/A
  • Revenue Growth
  • EVAX N/A
  • FOXO 196.03
  • 52 Week Low
  • EVAX $2.22
  • FOXO $0.13
  • 52 Week High
  • EVAX $23.70
  • FOXO $1.30
  • Technical
  • Relative Strength Index (RSI)
  • EVAX 41.09
  • FOXO 42.35
  • Support Level
  • EVAX $2.22
  • FOXO $0.22
  • Resistance Level
  • EVAX $4.05
  • FOXO $0.27
  • Average True Range (ATR)
  • EVAX 1.17
  • FOXO 0.04
  • MACD
  • EVAX 0.00
  • FOXO 0.00
  • Stochastic Oscillator
  • EVAX 6.99
  • FOXO 13.48

About EVAX Evaxion Biotech

Evaxion Biotech AS is a clinical-stage biotech company that aspires to the exploration of artificial intelligence, or AI, to develop immunotherapies with improved efficacy when compared to currently marketed products for patients with unmet medical needs. Its pipeline programs are derived from its proprietary AI platforms, PIONEER, EDEN, RAVEN, and ObsERV. The company is utilizing these AI platforms to build a drug development pipeline. Its product candidates are; EVX-01 and EVX-02, for the treatment of various cancers, and the third candidate is cancer immunotherapy, EVX-03, for the treatment of various cancers including non-small-cell-lung-cancer, or NSCLC, is in pre-clinical development.

About FOXO FOXO Technologies Inc.

FOXO Technologies Inc is a technology platform company focused on commercializing longevity science through products and services that serve the life insurance industry. FOXO's epigenetic technology applies AI to DNA methylation to identify molecular biomarkers of human health and aging. The company has two reportable business segments, FOXO Labs and FOXO Life.

Share on Social Networks: